| |
 |
|
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/246.1 |
Bacillus |
69 |
| 424/253.1 |
Bordetella (e.g., bordetella bronchiseptica, etc.) |
69 |
| 424/252.1 |
Brucella (e.g., brucella abortus, brucella canis, etc.) |
31 |
| 424/263.1 |
Chlamydia (e.g., chlamydia trachomatis, etc.) |
78 |
| 424/247.1 |
Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) |
98 |
| 424/245.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
47 |
| 424/257.1 |
Escherichia (e.g., escherichia coli, etc.) |
150 |
| 424/256.1 |
Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) |
196 |
| 424/259.1 |
Klebsiella (e.g., klebsiella pneumoniae, etc.) |
30 |
| 424/251.1 |
Moraxella (e.g., moraxella bovis, etc.) |
55 |
| 424/248.1 |
Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) |
233 |
| 424/264.1 |
Mycoplasma |
46 |
| 424/249.1 |
Neisseria (e.g., neisseria gonorrhoeae, etc.) |
93 |
| 424/255.1 |
Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) |
88 |
| 424/242.1 |
Pilus, fimbria, or adhesin |
81 |
| 424/260.1 |
Pseudomonas (e.g., pseudomonas aeruginosa, etc.) |
90 |
| 424/258.1 |
Salmonella (e.g., salmonella typhimurium, etc.) |
142 |
| 424/243.1 |
Staphylococcus (e.g., staphylococcus aureus, etc.) |
107 |
| 424/244.1 |
Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) |
300 |
| 424/236.1 |
Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
329 |
| 424/235.1 |
Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
94 |
| 424/262.1 |
Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) |
42 |
| 424/261.1 |
Vibrio (e.g., vibrio cholera, etc.) |
82 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6607725 |
Conjugate vaccine for nontypeable Haemophilus influenzae |
Aug. 19, 2003 |
| 6607728 |
Compounds and methods for the diagnosis and treatment of ehrlichia infection |
Aug. 19, 2003 |
| 6607729 |
Surface antigen |
Aug. 19, 2003 |
| 6607730 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Aug. 19, 2003 |
| 6607732 |
ISCOM or ISCOM-matrix comprising a mucous targetting substance and an antigen |
Aug. 19, 2003 |
| 6608187 |
C1 bacteriophage lytic system |
Aug. 19, 2003 |
| 6602506 |
Delivery of proteins into eukaryotic cells with recombinant Yersinia |
Aug. 5, 2003 |
| 6602508 |
Method of immunization using a Group B Streptococcus type II and type III polysaccharide conjugate vaccine |
Aug. 5, 2003 |
| 6599509 |
Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease |
Jul. 29, 2003 |
| 6599510 |
Abundant extracellular products and methods for their production and use |
Jul. 29, 2003 |
| 6596281 |
Mycobacterium tuberculosis specific proteins and genes, mixtures of antigens and uses thereof |
Jul. 22, 2003 |
| 6596282 |
Treatment of chronic viral infections with M. vaccae |
Jul. 22, 2003 |
| 6596477 |
Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid A |
Jul. 22, 2003 |
| 6596504 |
Treatment of prophylaxis of diseases caused by pilus-forming bacteria |
Jul. 22, 2003 |
| 6592875 |
Method for treatment of lyme disease |
Jul. 15, 2003 |
| 6585970 |
Method for treating hypothyroidism |
Jul. 1, 2003 |
| 6585975 |
Use of Salmonella vectors for vaccination against helicobacter infection |
Jul. 1, 2003 |
| 6585977 |
Non-virulent Porphyromonas gingivalis mutant |
Jul. 1, 2003 |
| 6585980 |
Flagellin gene, FlaC of Campylobacter |
Jul. 1, 2003 |
| 6585981 |
Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae |
Jul. 1, 2003 |
| 6582699 |
Combination vaccine for enhancing immunity against brucellosis |
Jun. 24, 2003 |
| 6582705 |
Acellular antibordetella vaccine |
Jun. 24, 2003 |
| 6582925 |
Desaturase antigen of mycobacterium tuberculosis |
Jun. 24, 2003 |
| 6576244 |
LT and CT in parenteral immunization methods against helicobacter infection |
Jun. 10, 2003 |
| 6572861 |
Adjuvants for use in vaccines |
Jun. 3, 2003 |
| 6572865 |
Mycobacterium tuberculosis DNA sequences encoding immunostimulatory peptides and methods for using same |
Jun. 3, 2003 |
| 6573003 |
Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease |
Jun. 3, 2003 |
| 6573064 |
Method of screening anti-mycobacterial molecules |
Jun. 3, 2003 |
| 6573090 |
Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors |
Jun. 3, 2003 |
| 6569435 |
Flavivirus and alphavirus recombinant antigen libraries |
May. 27, 2003 |
| 6565849 |
Methods of enhancing activity of vaccines and vaccine compositions |
May. 20, 2003 |
| 6565852 |
Methods and compositions for immunotherapy of cancer |
May. 20, 2003 |
| 6565854 |
Antimicrobial histone H1 compositions, kits, and methods of use thereof |
May. 20, 2003 |
| 6565855 |
Mycobacteria functional screening and/or expression vectors |
May. 20, 2003 |
| 6565888 |
Methods and compositions for the targeted delivery of biologically active agents |
May. 20, 2003 |
| 6562348 |
Recombinant M. tuberculosis auxotrophic for leucine and vaccines using same |
May. 13, 2003 |
| 6562349 |
Otitis media vaccine |
May. 13, 2003 |
| 6562630 |
Method for preparation and use of preservative-free immunoassay reagents |
May. 13, 2003 |
| 6558677 |
Vaccine against gram negative bacteria |
May. 6, 2003 |
| 6555115 |
Compounds and methods for treatment and diagnosis of chlamydial infection |
Apr. 29, 2003 |
| 6555331 |
Bacteriophage assay |
Apr. 29, 2003 |
| 6555653 |
Compounds for diagnosis of tuberculosis and methods for their use |
Apr. 29, 2003 |
| 6551599 |
Monoclonal antibodies against campylobacter jejuni and campylobacter coli outer membrane antigens |
Apr. 22, 2003 |
| 6548265 |
Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
Apr. 15, 2003 |
| 6548287 |
Non-pyrogenic bacterial strains and use of the same |
Apr. 15, 2003 |
| 6544517 |
Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis |
Apr. 8, 2003 |
| 6544519 |
Polypeptide originating in haemophilus paragallinarum and process for producing the same |
Apr. 8, 2003 |
| 6541000 |
Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response |
Apr. 1, 2003 |
| 6541007 |
Vaccine for Pseudomonas aeruginosa |
Apr. 1, 2003 |
| 6537558 |
Methods of producing and using virulence attenuated poxR mutant bacteria |
Mar. 25, 2003 |
|
|
|
